SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-068683
Filing Date
2024-06-04
Accepted
2024-06-04 16:15:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A avir-defa_14a_2024_proxy.htm DEFA14A 19315
2 GRAPHIC img100694052_0.jpg GRAPHIC 40265
  Complete submission text file 0000950170-24-068683.txt   75970
Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39661 | Film No.: 241018202
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)